Necina Roman 4
4 · HOOKIPA Pharma Inc. · Filed Apr 21, 2021
Insider Transaction Report
Form 4
Necina Roman
Chief Technology Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-19+36,750→ 36,750 totalExercise: $12.00Exp: 2031-04-19→ Common Stock (36,750 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on April 19, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.